StockData

Universe Pharmaceuticals INC (UPC) stock

UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.52−0.04 (-2.48%)

Close on Nov 18, 2026Market cap $857.01KP/E –Yield –

Universe Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $17.86B, down 22.4% from the year before. The highest annual figure on record is $32.31B in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Sep 30, 2025$17.86B-22.4%
FY2024Sep 30, 2024$23.02B-28.7%
FY2023Sep 30, 2023$32.31B+80383.8%
FY2022Sep 30, 2022$40.14M-16.3%
FY2021Sep 30, 2021$47.98M+56.3%
FY2020Sep 30, 2020$30.70M-7.6%
FY2019Sep 30, 2019$33.23M–

More Universe Pharmaceuticals figures

See a number that looks wrong?